Current clinical evidence supports the use of resveratrol as an anti-ageing drug
While preclinical laboratory research strongly supports resveratrol as a promising geroprotective agent via SIRT1 activation, clinical evidence in humans remains heterogeneous and limited by uncertain dosing and bioavailability, rendering its current status as an anti-ageing drug contested.
The claim is a specific and contestable scientific proposition about the current clinical efficacy of resveratrol as an anti-ageing drug. Several papers (0, 3, 8) discuss the strong preclinical and mechanistic evidence supporting its anti-ageing properties, particularly through sirtuin activation and oxidative stress reduction. However, papers (1, 5) point out that human clinical validation is limited, heterogeneous, and plagued by bioavailability and dosing uncertainties. Because robust clinical trials in humans do not definitively back the translation of preclinical promise into an established clinical anti-ageing drug, the appropriate balance verdict is CONTESTED.
Alameen AAM, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, Faheem SA, El-Saber Batiha G. SIRT1 Activators as Geroprotective Agents in Brain Aging: Mechanisms and Therapeutic Potential.. 2026. https://doi.org/10.1007/s12017-026-08923-y
Paper 0 highlights that SIRT1 activators like resveratrol act as geroprotective agents by reducing cellular senescence and oxidative stress in the brain.
Kurtz JA, Singleton KM, Vasenina E, Jäger R, Gonzalez D, Schwarz A, Howard J, Antonio J. Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits.. 2026. https://doi.org/10.1007/s13668-026-00776-y
Paper 1 notes considerable heterogeneity in human clinical studies and variable dosing efficacy for antioxidant and mitochondrial-targeted compounds in older adults.
See more details
Yılmaz A, Park HJ, Ahn EM, Bae J. Dietary Polyphenols in Aging: A Systems-Level Perspective on Mitochondrial Quality Control and Microbiome Interactions.. 2026. https://doi.org/10.3390/ijms27093930
Paper 3 notes that dietary polyphenols such as resveratrol modulate hallmarks of aging through pathways like AMPK and sirtuins to support healthspan.
Ayşe Acar, Esra Aydemir, Bülent Kaya. Antineoplastic, longevity, and antimutagenic effect of resveratrol. 2026. https://doi.org/10.4103/amah.amh-2025-04-037
Paper 8 reviews extensive laboratory studies indicating that resveratrol exhibits antioxidant, neuroprotective, and anti-ageing properties via SIRT1 activation.
Li Y, Wu H, Zhang Z, Wang M, Zhao Y, Sun H. Natural Small Molecules Targeting Oxidative Stress and Redox Homeostasis in Aging: Mechanisms and Therapeutic Potential.. 2026. https://doi.org/10.3390/antiox15050621
Paper 5 emphasizes that the clinical evidence base for plant-derived anti-ageing monomers remains heterogeneous, with limited reliable clinical validation and uncertain dose-exposure relationships.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt